Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Serum Separation Gel Market

ID: MRFR/HC/39095-HCR
128 Pages
Rahul Gotadki
Last Updated: April 06, 2026

Serum Separation Gel Market Research Report By Product Type (Silica-Based Serum Separation Gel, Polymer-Based Serum Separation Gel, Hybrid Serum Separation Gel), By Application (Clinical Diagnostics, Research and Development, Drug Development, Transfusion Medicine), By End User (Hospitals and Clinics, Diagnostic Laboratories, Research Institutes, Pharmaceutical Companies), By Form Factor (Tubes, Vials, Centrifuge Tubes, Microwell Plates), By Sample Type (Blood, Serum, Plasma, Urine, Other Body Fluids) and By Regional (North America, Europe, South America, Asia-Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Serum Separation Gel Market Infographic
Purchase Options
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Healthcare, BY Product Type (USD Billion)
  49.     4.1.1 Silica-Based Serum Separation Gel
  50.     4.1.2 Polymer-Based Serum Separation Gel
  51.     4.1.3 Hybrid Serum Separation Gel
  52.   4.2 Healthcare, BY Application (USD Billion)
  53.     4.2.1 Clinical Diagnostics
  54.     4.2.2 Research and Development
  55.     4.2.3 Drug Development
  56.     4.2.4 Transfusion Medicine
  57.   4.3 Healthcare, BY End User (USD Billion)
  58.     4.3.1 Hospitals and Clinics
  59.     4.3.2 Diagnostic Laboratories
  60.     4.3.3 Research Institutes
  61.     4.3.4 Pharmaceutical Companies
  62.   4.4 Healthcare, BY Form Factor (USD Billion)
  63.     4.4.1 Tubes
  64.     4.4.2 Vials
  65.     4.4.3 Centrifuge Tubes
  66.     4.4.4 Microwell Plates
  67.   4.5 Healthcare, BY Sample Type (USD Billion)
  68.     4.5.1 Blood
  69.     4.5.2 Serum
  70.     4.5.3 Plasma
  71.     4.5.4 Urine
  72.     4.5.5 Other Body Fluids
  73.   4.6 Healthcare, BY Region (USD Billion)
  74.     4.6.1 North America
  75.       4.6.1.1 US
  76.       4.6.1.2 Canada
  77.     4.6.2 Europe
  78.       4.6.2.1 Germany
  79.       4.6.2.2 UK
  80.       4.6.2.3 France
  81.       4.6.2.4 Russia
  82.       4.6.2.5 Italy
  83.       4.6.2.6 Spain
  84.       4.6.2.7 Rest of Europe
  85.     4.6.3 APAC
  86.       4.6.3.1 China
  87.       4.6.3.2 India
  88.       4.6.3.3 Japan
  89.       4.6.3.4 South Korea
  90.       4.6.3.5 Malaysia
  91.       4.6.3.6 Thailand
  92.       4.6.3.7 Indonesia
  93.       4.6.3.8 Rest of APAC
  94.     4.6.4 South America
  95.       4.6.4.1 Brazil
  96.       4.6.4.2 Mexico
  97.       4.6.4.3 Argentina
  98.       4.6.4.4 Rest of South America
  99.     4.6.5 MEA
  100.       4.6.5.1 GCC Countries
  101.       4.6.5.2 South Africa
  102.       4.6.5.3 Rest of MEA
  103. 5 SECTION V: COMPETITIVE ANALYSIS
  104.   5.1 Competitive Landscape
  105.     5.1.1 Overview
  106.     5.1.2 Competitive Analysis
  107.     5.1.3 Market share Analysis
  108.     5.1.4 Major Growth Strategy in the Healthcare
  109.     5.1.5 Competitive Benchmarking
  110.     5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  111.     5.1.7 Key developments and growth strategies
  112.       5.1.7.1 New Product Launch/Service Deployment
  113.       5.1.7.2 Merger & Acquisitions
  114.       5.1.7.3 Joint Ventures
  115.     5.1.8 Major Players Financial Matrix
  116.       5.1.8.1 Sales and Operating Income
  117.       5.1.8.2 Major Players R&D Expenditure. 2023
  118.   5.2 Company Profiles
  119.     5.2.1 BD (US)
  120.       5.2.1.1 Financial Overview
  121.       5.2.1.2 Products Offered
  122.       5.2.1.3 Key Developments
  123.       5.2.1.4 SWOT Analysis
  124.       5.2.1.5 Key Strategies
  125.     5.2.2 Greiner Bio-One (DE)
  126.       5.2.2.1 Financial Overview
  127.       5.2.2.2 Products Offered
  128.       5.2.2.3 Key Developments
  129.       5.2.2.4 SWOT Analysis
  130.       5.2.2.5 Key Strategies
  131.     5.2.3 Terumo Corporation (JP)
  132.       5.2.3.1 Financial Overview
  133.       5.2.3.2 Products Offered
  134.       5.2.3.3 Key Developments
  135.       5.2.3.4 SWOT Analysis
  136.       5.2.3.5 Key Strategies
  137.     5.2.4 Sarstedt AG (DE)
  138.       5.2.4.1 Financial Overview
  139.       5.2.4.2 Products Offered
  140.       5.2.4.3 Key Developments
  141.       5.2.4.4 SWOT Analysis
  142.       5.2.4.5 Key Strategies
  143.     5.2.5 Fisher Scientific (US)
  144.       5.2.5.1 Financial Overview
  145.       5.2.5.2 Products Offered
  146.       5.2.5.3 Key Developments
  147.       5.2.5.4 SWOT Analysis
  148.       5.2.5.5 Key Strategies
  149.     5.2.6 Roche Diagnostics (CH)
  150.       5.2.6.1 Financial Overview
  151.       5.2.6.2 Products Offered
  152.       5.2.6.3 Key Developments
  153.       5.2.6.4 SWOT Analysis
  154.       5.2.6.5 Key Strategies
  155.     5.2.7 Merck KGaA (DE)
  156.       5.2.7.1 Financial Overview
  157.       5.2.7.2 Products Offered
  158.       5.2.7.3 Key Developments
  159.       5.2.7.4 SWOT Analysis
  160.       5.2.7.5 Key Strategies
  161.     5.2.8 Qiagen (DE)
  162.       5.2.8.1 Financial Overview
  163.       5.2.8.2 Products Offered
  164.       5.2.8.3 Key Developments
  165.       5.2.8.4 SWOT Analysis
  166.       5.2.8.5 Key Strategies
  167.   5.3 Appendix
  168.     5.3.1 References
  169.     5.3.2 Related Reports
  170. 6 LIST OF FIGURES
  171.   6.1 MARKET SYNOPSIS
  172.   6.2 NORTH AMERICA MARKET ANALYSIS
  173.   6.3 US MARKET ANALYSIS BY PRODUCT TYPE
  174.   6.4 US MARKET ANALYSIS BY APPLICATION
  175.   6.5 US MARKET ANALYSIS BY END USER
  176.   6.6 US MARKET ANALYSIS BY FORM FACTOR
  177.   6.7 US MARKET ANALYSIS BY SAMPLE TYPE
  178.   6.8 CANADA MARKET ANALYSIS BY PRODUCT TYPE
  179.   6.9 CANADA MARKET ANALYSIS BY APPLICATION
  180.   6.10 CANADA MARKET ANALYSIS BY END USER
  181.   6.11 CANADA MARKET ANALYSIS BY FORM FACTOR
  182.   6.12 CANADA MARKET ANALYSIS BY SAMPLE TYPE
  183.   6.13 EUROPE MARKET ANALYSIS
  184.   6.14 GERMANY MARKET ANALYSIS BY PRODUCT TYPE
  185.   6.15 GERMANY MARKET ANALYSIS BY APPLICATION
  186.   6.16 GERMANY MARKET ANALYSIS BY END USER
  187.   6.17 GERMANY MARKET ANALYSIS BY FORM FACTOR
  188.   6.18 GERMANY MARKET ANALYSIS BY SAMPLE TYPE
  189.   6.19 UK MARKET ANALYSIS BY PRODUCT TYPE
  190.   6.20 UK MARKET ANALYSIS BY APPLICATION
  191.   6.21 UK MARKET ANALYSIS BY END USER
  192.   6.22 UK MARKET ANALYSIS BY FORM FACTOR
  193.   6.23 UK MARKET ANALYSIS BY SAMPLE TYPE
  194.   6.24 FRANCE MARKET ANALYSIS BY PRODUCT TYPE
  195.   6.25 FRANCE MARKET ANALYSIS BY APPLICATION
  196.   6.26 FRANCE MARKET ANALYSIS BY END USER
  197.   6.27 FRANCE MARKET ANALYSIS BY FORM FACTOR
  198.   6.28 FRANCE MARKET ANALYSIS BY SAMPLE TYPE
  199.   6.29 RUSSIA MARKET ANALYSIS BY PRODUCT TYPE
  200.   6.30 RUSSIA MARKET ANALYSIS BY APPLICATION
  201.   6.31 RUSSIA MARKET ANALYSIS BY END USER
  202.   6.32 RUSSIA MARKET ANALYSIS BY FORM FACTOR
  203.   6.33 RUSSIA MARKET ANALYSIS BY SAMPLE TYPE
  204.   6.34 ITALY MARKET ANALYSIS BY PRODUCT TYPE
  205.   6.35 ITALY MARKET ANALYSIS BY APPLICATION
  206.   6.36 ITALY MARKET ANALYSIS BY END USER
  207.   6.37 ITALY MARKET ANALYSIS BY FORM FACTOR
  208.   6.38 ITALY MARKET ANALYSIS BY SAMPLE TYPE
  209.   6.39 SPAIN MARKET ANALYSIS BY PRODUCT TYPE
  210.   6.40 SPAIN MARKET ANALYSIS BY APPLICATION
  211.   6.41 SPAIN MARKET ANALYSIS BY END USER
  212.   6.42 SPAIN MARKET ANALYSIS BY FORM FACTOR
  213.   6.43 SPAIN MARKET ANALYSIS BY SAMPLE TYPE
  214.   6.44 REST OF EUROPE MARKET ANALYSIS BY PRODUCT TYPE
  215.   6.45 REST OF EUROPE MARKET ANALYSIS BY APPLICATION
  216.   6.46 REST OF EUROPE MARKET ANALYSIS BY END USER
  217.   6.47 REST OF EUROPE MARKET ANALYSIS BY FORM FACTOR
  218.   6.48 REST OF EUROPE MARKET ANALYSIS BY SAMPLE TYPE
  219.   6.49 APAC MARKET ANALYSIS
  220.   6.50 CHINA MARKET ANALYSIS BY PRODUCT TYPE
  221.   6.51 CHINA MARKET ANALYSIS BY APPLICATION
  222.   6.52 CHINA MARKET ANALYSIS BY END USER
  223.   6.53 CHINA MARKET ANALYSIS BY FORM FACTOR
  224.   6.54 CHINA MARKET ANALYSIS BY SAMPLE TYPE
  225.   6.55 INDIA MARKET ANALYSIS BY PRODUCT TYPE
  226.   6.56 INDIA MARKET ANALYSIS BY APPLICATION
  227.   6.57 INDIA MARKET ANALYSIS BY END USER
  228.   6.58 INDIA MARKET ANALYSIS BY FORM FACTOR
  229.   6.59 INDIA MARKET ANALYSIS BY SAMPLE TYPE
  230.   6.60 JAPAN MARKET ANALYSIS BY PRODUCT TYPE
  231.   6.61 JAPAN MARKET ANALYSIS BY APPLICATION
  232.   6.62 JAPAN MARKET ANALYSIS BY END USER
  233.   6.63 JAPAN MARKET ANALYSIS BY FORM FACTOR
  234.   6.64 JAPAN MARKET ANALYSIS BY SAMPLE TYPE
  235.   6.65 SOUTH KOREA MARKET ANALYSIS BY PRODUCT TYPE
  236.   6.66 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
  237.   6.67 SOUTH KOREA MARKET ANALYSIS BY END USER
  238.   6.68 SOUTH KOREA MARKET ANALYSIS BY FORM FACTOR
  239.   6.69 SOUTH KOREA MARKET ANALYSIS BY SAMPLE TYPE
  240.   6.70 MALAYSIA MARKET ANALYSIS BY PRODUCT TYPE
  241.   6.71 MALAYSIA MARKET ANALYSIS BY APPLICATION
  242.   6.72 MALAYSIA MARKET ANALYSIS BY END USER
  243.   6.73 MALAYSIA MARKET ANALYSIS BY FORM FACTOR
  244.   6.74 MALAYSIA MARKET ANALYSIS BY SAMPLE TYPE
  245.   6.75 THAILAND MARKET ANALYSIS BY PRODUCT TYPE
  246.   6.76 THAILAND MARKET ANALYSIS BY APPLICATION
  247.   6.77 THAILAND MARKET ANALYSIS BY END USER
  248.   6.78 THAILAND MARKET ANALYSIS BY FORM FACTOR
  249.   6.79 THAILAND MARKET ANALYSIS BY SAMPLE TYPE
  250.   6.80 INDONESIA MARKET ANALYSIS BY PRODUCT TYPE
  251.   6.81 INDONESIA MARKET ANALYSIS BY APPLICATION
  252.   6.82 INDONESIA MARKET ANALYSIS BY END USER
  253.   6.83 INDONESIA MARKET ANALYSIS BY FORM FACTOR
  254.   6.84 INDONESIA MARKET ANALYSIS BY SAMPLE TYPE
  255.   6.85 REST OF APAC MARKET ANALYSIS BY PRODUCT TYPE
  256.   6.86 REST OF APAC MARKET ANALYSIS BY APPLICATION
  257.   6.87 REST OF APAC MARKET ANALYSIS BY END USER
  258.   6.88 REST OF APAC MARKET ANALYSIS BY FORM FACTOR
  259.   6.89 REST OF APAC MARKET ANALYSIS BY SAMPLE TYPE
  260.   6.90 SOUTH AMERICA MARKET ANALYSIS
  261.   6.91 BRAZIL MARKET ANALYSIS BY PRODUCT TYPE
  262.   6.92 BRAZIL MARKET ANALYSIS BY APPLICATION
  263.   6.93 BRAZIL MARKET ANALYSIS BY END USER
  264.   6.94 BRAZIL MARKET ANALYSIS BY FORM FACTOR
  265.   6.95 BRAZIL MARKET ANALYSIS BY SAMPLE TYPE
  266.   6.96 MEXICO MARKET ANALYSIS BY PRODUCT TYPE
  267.   6.97 MEXICO MARKET ANALYSIS BY APPLICATION
  268.   6.98 MEXICO MARKET ANALYSIS BY END USER
  269.   6.99 MEXICO MARKET ANALYSIS BY FORM FACTOR
  270.   6.100 MEXICO MARKET ANALYSIS BY SAMPLE TYPE
  271.   6.101 ARGENTINA MARKET ANALYSIS BY PRODUCT TYPE
  272.   6.102 ARGENTINA MARKET ANALYSIS BY APPLICATION
  273.   6.103 ARGENTINA MARKET ANALYSIS BY END USER
  274.   6.104 ARGENTINA MARKET ANALYSIS BY FORM FACTOR
  275.   6.105 ARGENTINA MARKET ANALYSIS BY SAMPLE TYPE
  276.   6.106 REST OF SOUTH AMERICA MARKET ANALYSIS BY PRODUCT TYPE
  277.   6.107 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
  278.   6.108 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USER
  279.   6.109 REST OF SOUTH AMERICA MARKET ANALYSIS BY FORM FACTOR
  280.   6.110 REST OF SOUTH AMERICA MARKET ANALYSIS BY SAMPLE TYPE
  281.   6.111 MEA MARKET ANALYSIS
  282.   6.112 GCC COUNTRIES MARKET ANALYSIS BY PRODUCT TYPE
  283.   6.113 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION
  284.   6.114 GCC COUNTRIES MARKET ANALYSIS BY END USER
  285.   6.115 GCC COUNTRIES MARKET ANALYSIS BY FORM FACTOR
  286.   6.116 GCC COUNTRIES MARKET ANALYSIS BY SAMPLE TYPE
  287.   6.117 SOUTH AFRICA MARKET ANALYSIS BY PRODUCT TYPE
  288.   6.118 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION
  289.   6.119 SOUTH AFRICA MARKET ANALYSIS BY END USER
  290.   6.120 SOUTH AFRICA MARKET ANALYSIS BY FORM FACTOR
  291.   6.121 SOUTH AFRICA MARKET ANALYSIS BY SAMPLE TYPE
  292.   6.122 REST OF MEA MARKET ANALYSIS BY PRODUCT TYPE
  293.   6.123 REST OF MEA MARKET ANALYSIS BY APPLICATION
  294.   6.124 REST OF MEA MARKET ANALYSIS BY END USER
  295.   6.125 REST OF MEA MARKET ANALYSIS BY FORM FACTOR
  296.   6.126 REST OF MEA MARKET ANALYSIS BY SAMPLE TYPE
  297.   6.127 KEY BUYING CRITERIA OF HEALTHCARE
  298.   6.128 RESEARCH PROCESS OF MRFR
  299.   6.129 DRO ANALYSIS OF HEALTHCARE
  300.   6.130 DRIVERS IMPACT ANALYSIS: HEALTHCARE
  301.   6.131 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
  302.   6.132 SUPPLY / VALUE CHAIN: HEALTHCARE
  303.   6.133 HEALTHCARE, BY PRODUCT TYPE, 2024 (% SHARE)
  304.   6.134 HEALTHCARE, BY PRODUCT TYPE, 2024 TO 2035 (USD Billion)
  305.   6.135 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
  306.   6.136 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion)
  307.   6.137 HEALTHCARE, BY END USER, 2024 (% SHARE)
  308.   6.138 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Billion)
  309.   6.139 HEALTHCARE, BY FORM FACTOR, 2024 (% SHARE)
  310.   6.140 HEALTHCARE, BY FORM FACTOR, 2024 TO 2035 (USD Billion)
  311.   6.141 HEALTHCARE, BY SAMPLE TYPE, 2024 (% SHARE)
  312.   6.142 HEALTHCARE, BY SAMPLE TYPE, 2024 TO 2035 (USD Billion)
  313.   6.143 BENCHMARKING OF MAJOR COMPETITORS
  314. 7 LIST OF TABLES
  315.   7.1 LIST OF ASSUMPTIONS
  316.     7.1.1
  317.   7.2 North America MARKET SIZE ESTIMATES; FORECAST
  318.     7.2.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  319.     7.2.2 BY APPLICATION, 2025-2035 (USD Billion)
  320.     7.2.3 BY END USER, 2025-2035 (USD Billion)
  321.     7.2.4 BY FORM FACTOR, 2025-2035 (USD Billion)
  322.     7.2.5 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  323.   7.3 US MARKET SIZE ESTIMATES; FORECAST
  324.     7.3.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  325.     7.3.2 BY APPLICATION, 2025-2035 (USD Billion)
  326.     7.3.3 BY END USER, 2025-2035 (USD Billion)
  327.     7.3.4 BY FORM FACTOR, 2025-2035 (USD Billion)
  328.     7.3.5 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  329.   7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  330.     7.4.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  331.     7.4.2 BY APPLICATION, 2025-2035 (USD Billion)
  332.     7.4.3 BY END USER, 2025-2035 (USD Billion)
  333.     7.4.4 BY FORM FACTOR, 2025-2035 (USD Billion)
  334.     7.4.5 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  335.   7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  336.     7.5.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  337.     7.5.2 BY APPLICATION, 2025-2035 (USD Billion)
  338.     7.5.3 BY END USER, 2025-2035 (USD Billion)
  339.     7.5.4 BY FORM FACTOR, 2025-2035 (USD Billion)
  340.     7.5.5 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  341.   7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  342.     7.6.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  343.     7.6.2 BY APPLICATION, 2025-2035 (USD Billion)
  344.     7.6.3 BY END USER, 2025-2035 (USD Billion)
  345.     7.6.4 BY FORM FACTOR, 2025-2035 (USD Billion)
  346.     7.6.5 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  347.   7.7 UK MARKET SIZE ESTIMATES; FORECAST
  348.     7.7.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  349.     7.7.2 BY APPLICATION, 2025-2035 (USD Billion)
  350.     7.7.3 BY END USER, 2025-2035 (USD Billion)
  351.     7.7.4 BY FORM FACTOR, 2025-2035 (USD Billion)
  352.     7.7.5 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  353.   7.8 France MARKET SIZE ESTIMATES; FORECAST
  354.     7.8.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  355.     7.8.2 BY APPLICATION, 2025-2035 (USD Billion)
  356.     7.8.3 BY END USER, 2025-2035 (USD Billion)
  357.     7.8.4 BY FORM FACTOR, 2025-2035 (USD Billion)
  358.     7.8.5 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  359.   7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  360.     7.9.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  361.     7.9.2 BY APPLICATION, 2025-2035 (USD Billion)
  362.     7.9.3 BY END USER, 2025-2035 (USD Billion)
  363.     7.9.4 BY FORM FACTOR, 2025-2035 (USD Billion)
  364.     7.9.5 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  365.   7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  366.     7.10.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  367.     7.10.2 BY APPLICATION, 2025-2035 (USD Billion)
  368.     7.10.3 BY END USER, 2025-2035 (USD Billion)
  369.     7.10.4 BY FORM FACTOR, 2025-2035 (USD Billion)
  370.     7.10.5 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  371.   7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  372.     7.11.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  373.     7.11.2 BY APPLICATION, 2025-2035 (USD Billion)
  374.     7.11.3 BY END USER, 2025-2035 (USD Billion)
  375.     7.11.4 BY FORM FACTOR, 2025-2035 (USD Billion)
  376.     7.11.5 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  377.   7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  378.     7.12.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  379.     7.12.2 BY APPLICATION, 2025-2035 (USD Billion)
  380.     7.12.3 BY END USER, 2025-2035 (USD Billion)
  381.     7.12.4 BY FORM FACTOR, 2025-2035 (USD Billion)
  382.     7.12.5 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  383.   7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  384.     7.13.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  385.     7.13.2 BY APPLICATION, 2025-2035 (USD Billion)
  386.     7.13.3 BY END USER, 2025-2035 (USD Billion)
  387.     7.13.4 BY FORM FACTOR, 2025-2035 (USD Billion)
  388.     7.13.5 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  389.   7.14 China MARKET SIZE ESTIMATES; FORECAST
  390.     7.14.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  391.     7.14.2 BY APPLICATION, 2025-2035 (USD Billion)
  392.     7.14.3 BY END USER, 2025-2035 (USD Billion)
  393.     7.14.4 BY FORM FACTOR, 2025-2035 (USD Billion)
  394.     7.14.5 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  395.   7.15 India MARKET SIZE ESTIMATES; FORECAST
  396.     7.15.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  397.     7.15.2 BY APPLICATION, 2025-2035 (USD Billion)
  398.     7.15.3 BY END USER, 2025-2035 (USD Billion)
  399.     7.15.4 BY FORM FACTOR, 2025-2035 (USD Billion)
  400.     7.15.5 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  401.   7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  402.     7.16.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  403.     7.16.2 BY APPLICATION, 2025-2035 (USD Billion)
  404.     7.16.3 BY END USER, 2025-2035 (USD Billion)
  405.     7.16.4 BY FORM FACTOR, 2025-2035 (USD Billion)
  406.     7.16.5 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  407.   7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  408.     7.17.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  409.     7.17.2 BY APPLICATION, 2025-2035 (USD Billion)
  410.     7.17.3 BY END USER, 2025-2035 (USD Billion)
  411.     7.17.4 BY FORM FACTOR, 2025-2035 (USD Billion)
  412.     7.17.5 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  413.   7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  414.     7.18.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  415.     7.18.2 BY APPLICATION, 2025-2035 (USD Billion)
  416.     7.18.3 BY END USER, 2025-2035 (USD Billion)
  417.     7.18.4 BY FORM FACTOR, 2025-2035 (USD Billion)
  418.     7.18.5 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  419.   7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  420.     7.19.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  421.     7.19.2 BY APPLICATION, 2025-2035 (USD Billion)
  422.     7.19.3 BY END USER, 2025-2035 (USD Billion)
  423.     7.19.4 BY FORM FACTOR, 2025-2035 (USD Billion)
  424.     7.19.5 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  425.   7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  426.     7.20.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  427.     7.20.2 BY APPLICATION, 2025-2035 (USD Billion)
  428.     7.20.3 BY END USER, 2025-2035 (USD Billion)
  429.     7.20.4 BY FORM FACTOR, 2025-2035 (USD Billion)
  430.     7.20.5 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  431.   7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  432.     7.21.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  433.     7.21.2 BY APPLICATION, 2025-2035 (USD Billion)
  434.     7.21.3 BY END USER, 2025-2035 (USD Billion)
  435.     7.21.4 BY FORM FACTOR, 2025-2035 (USD Billion)
  436.     7.21.5 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  437.   7.22 South America MARKET SIZE ESTIMATES; FORECAST
  438.     7.22.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  439.     7.22.2 BY APPLICATION, 2025-2035 (USD Billion)
  440.     7.22.3 BY END USER, 2025-2035 (USD Billion)
  441.     7.22.4 BY FORM FACTOR, 2025-2035 (USD Billion)
  442.     7.22.5 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  443.   7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  444.     7.23.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  445.     7.23.2 BY APPLICATION, 2025-2035 (USD Billion)
  446.     7.23.3 BY END USER, 2025-2035 (USD Billion)
  447.     7.23.4 BY FORM FACTOR, 2025-2035 (USD Billion)
  448.     7.23.5 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  449.   7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  450.     7.24.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  451.     7.24.2 BY APPLICATION, 2025-2035 (USD Billion)
  452.     7.24.3 BY END USER, 2025-2035 (USD Billion)
  453.     7.24.4 BY FORM FACTOR, 2025-2035 (USD Billion)
  454.     7.24.5 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  455.   7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  456.     7.25.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  457.     7.25.2 BY APPLICATION, 2025-2035 (USD Billion)
  458.     7.25.3 BY END USER, 2025-2035 (USD Billion)
  459.     7.25.4 BY FORM FACTOR, 2025-2035 (USD Billion)
  460.     7.25.5 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  461.   7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  462.     7.26.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  463.     7.26.2 BY APPLICATION, 2025-2035 (USD Billion)
  464.     7.26.3 BY END USER, 2025-2035 (USD Billion)
  465.     7.26.4 BY FORM FACTOR, 2025-2035 (USD Billion)
  466.     7.26.5 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  467.   7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  468.     7.27.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  469.     7.27.2 BY APPLICATION, 2025-2035 (USD Billion)
  470.     7.27.3 BY END USER, 2025-2035 (USD Billion)
  471.     7.27.4 BY FORM FACTOR, 2025-2035 (USD Billion)
  472.     7.27.5 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  473.   7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  474.     7.28.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  475.     7.28.2 BY APPLICATION, 2025-2035 (USD Billion)
  476.     7.28.3 BY END USER, 2025-2035 (USD Billion)
  477.     7.28.4 BY FORM FACTOR, 2025-2035 (USD Billion)
  478.     7.28.5 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  479.   7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  480.     7.29.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  481.     7.29.2 BY APPLICATION, 2025-2035 (USD Billion)
  482.     7.29.3 BY END USER, 2025-2035 (USD Billion)
  483.     7.29.4 BY FORM FACTOR, 2025-2035 (USD Billion)
  484.     7.29.5 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  485.   7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  486.     7.30.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  487.     7.30.2 BY APPLICATION, 2025-2035 (USD Billion)
  488.     7.30.3 BY END USER, 2025-2035 (USD Billion)
  489.     7.30.4 BY FORM FACTOR, 2025-2035 (USD Billion)
  490.     7.30.5 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  491.   7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  492.     7.31.1
  493.   7.32 ACQUISITION/PARTNERSHIP
  494.     7.32.1

Healthcare Market Segmentation

Healthcare By Product Type (USD Billion, 2025-2035)

  • Silica-Based Serum Separation Gel
  • Polymer-Based Serum Separation Gel
  • Hybrid Serum Separation Gel

Healthcare By Application (USD Billion, 2025-2035)

  • Clinical Diagnostics
  • Research and Development
  • Drug Development
  • Transfusion Medicine

Healthcare By End User (USD Billion, 2025-2035)

  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Research Institutes
  • Pharmaceutical Companies

Healthcare By Form Factor (USD Billion, 2025-2035)

  • Tubes
  • Vials
  • Centrifuge Tubes
  • Microwell Plates

Healthcare By Sample Type (USD Billion, 2025-2035)

  • Blood
  • Serum
  • Plasma
  • Urine
  • Other Body Fluids

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions